Registry of Lobbyists
Total Number of Communication Reports: 0
Monthly communication reports in the last 6 months: 0
Version 3 of 6 (2007-10-17 to 2008-04-08) was submitted prior to the Lobbying Act coming into force on July 2, 2008. Due to different information requirements at that time, the registration is presented in the following format.
| Corporation: |
Bristol Myers Squibb Canada
2365 Cote de Liesse St Laurent, QC H4N 2M7 Canada |
| Telephone number: | 514-333-2500 |
| Fax number: | 514-331-6652 |
| Responsible officer name and position during the period of this registration: | Wayne Quigley, President and General Manager |
| Description of activities: | BMS Canada imports, markets and sells prescription drugs in several therapeutic areas, including, but not limited to cancer, heart disease, high blood pressure, AIDS, diabetes and depression. |
| The client is a subsidiary of the following parent companies: |
Brystol Myers Squibb
345 Park Avenue New York, NY United States of America 10154-0037 |
| Coalition | The corporation is not a member of a coalition. |
| Subsidiary: | The corporation does not have any subsidiaries that could be affected by the outcome of the undertaking. |
| Other direct interests | The corporation's activities are not controlled or directed by another individual, organization or corporation with a direct interest in the outcome of this undertaking. |
| Was the corporation funded in whole or in part by any domestic or foreign government institution in the last completed financial year? | No |
| Name: | Jean-Paul Bedard |
| Position title: | Vice President, Corporate Affairs |
| Public offices held: | No |
| Name: | Marc Osborne |
| Position title: | Director Public Affairs and Government Relations |
| Public offices held: | No |
| Name: | Wayne Quigley |
| Position title: | President |
| Public offices held: | No |
| Federal departments or organizations which have been or will be communicated with during the course of the undertaking: | Canadian International Development Agency (CIDA), Finance Canada (FIN), Foreign Affairs and International Trade Canada (DFAITC), Health Canada (HC), Industry Canada, Members of the House of Commons, National Defence (DND), Patented Medicine Prices Review Board (PMPRB), Prime Minister's Office (PMO), Privy Council Office (PCO), Public Works and Government Services Canada, Senate of Canada, Treasury Board Of Canada Secretariat (TBS) | ||||||||
|
Communication techniques that have been used or are expected to be used in the course of the undertaking:
|
Grass-roots communication, Informal communications, Meetings, Presentations, Telephone calls, Written communications, whether in hard copy or electronic format | ||||||||
| Subject Matter: Areas of Concern: | Constitutional Issues, Consumer Issues, Defence, Government Procurement, Health, Industry, Intellectual Property, International Trade, Science and Technology, Taxation and Finance | ||||||||
| Subject Matter: Retrospective: | Intellectual Property, Cross Border Trade, National Pharmaceutical Strategy, Canadian Agency for Drugs and Technologies in Health (CADTH), Drug Formularies, Patented Medicines Prices Review Board (PMPRB), Cancer Strategy, Federal Accoutability Act | ||||||||
| Subject Matter: Prospective: | Intellectual Property, Cross Border Trade, National Pharmaceutical Strategy, Drug Formularies, PMPRB, Cancer Strategy, Federal Accountability Act, Canadian Agency for Drugs and Technologies in Health(CADTH) | ||||||||
Details Regarding the Identified Subject Matter
|
|||||||||